Heterogeneous nuclear RNPs as targets of autoantibodies in systemic rheumatic diseases

K Op De Beeck; L Maes; Karien Bergh; R Derua; E Waelkens; K Van Steen; P Vermeersch; R Westhovens; K de Vlam; P Verschueren; H (Herbert) Hooijkaas; D Blockmans; X Bossuyt

doi:10.1002/art.33327

Heterogeneous nuclear RNPs as targets of autoantibodies in systemic rheumatic diseases

K Op De Beeck, L Maes, Karien Bergh, R Derua, E Waelkens, K Van Steen, P Vermeersch, R Westhovens, K de Vlam, P Verschueren, H (Herbert) Hooijkaas, D Blockmans, X Bossuyt

Research output: Contribution to journal › Article › Academic › peer-review

14 Citations (Scopus)

Abstract

Objective To investigate the abundance of autoantibodies to heterogeneous nuclear RNPs (hnRNPs) in systemic rheumatic diseases. Methods. Recombinant human hnRNPs A1, B1, C1, E1, F, Gi, H1, I, K, and P2 were prepared. Antibodies to these antigens were determined by Western blotting and by enzyme-linked immunosorbent assay (ELISA) (for hnRNPs B1, E1, F, and H1) in serum samples obtained from patients with chronic fatigue syndrome (control subjects) and from patients with various connective tissue diseases. Results. Western blotting analysis in 106 control subjects and 298 patients with a connective tissue disease revealed that antibodies to all tested hnRNP antigens, except hnRNP Gi, were significantly more prevalent in patients with Sjogren's syndrome (SS) than in control subjects. The highest reactivity was observed for hnRNPs B1, E1, F, and H1 (reactivity in >45% of patients with SS and in 2.8% of control subjects). Reactivity with hnRNPs B1, E1, F, and H1 was also evaluated by ELISA in 89 cont Conclusion. Several hnRNPs are target antigens in SS. The combined presence of antibodies to several hnRNPs was strongly associated with connective tissue disease in general and with SS in particular.

Original language	Undefined/Unknown
Pages (from-to)	213-221
Number of pages	9
Journal	Arthritis & Rheumatism
Volume	64
Issue number	1
DOIs	https://doi.org/10.1002/art.33327
Publication status	Published - 2012

Research programs

EMC MM-02-72-02

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/art.33327

http://hdl.handle.net/1765/34785

Cite this

@article{f5f97350f3e8480b9c7a2a1edd288b52,

title = "Heterogeneous nuclear RNPs as targets of autoantibodies in systemic rheumatic diseases",

abstract = "Objective To investigate the abundance of autoantibodies to heterogeneous nuclear RNPs (hnRNPs) in systemic rheumatic diseases. Methods. Recombinant human hnRNPs A1, B1, C1, E1, F, Gi, H1, I, K, and P2 were prepared. Antibodies to these antigens were determined by Western blotting and by enzyme-linked immunosorbent assay (ELISA) (for hnRNPs B1, E1, F, and H1) in serum samples obtained from patients with chronic fatigue syndrome (control subjects) and from patients with various connective tissue diseases. Results. Western blotting analysis in 106 control subjects and 298 patients with a connective tissue disease revealed that antibodies to all tested hnRNP antigens, except hnRNP Gi, were significantly more prevalent in patients with Sjogren's syndrome (SS) than in control subjects. The highest reactivity was observed for hnRNPs B1, E1, F, and H1 (reactivity in >45% of patients with SS and in 2.8% of control subjects). Reactivity with hnRNPs B1, E1, F, and H1 was also evaluated by ELISA in 89 cont Conclusion. Several hnRNPs are target antigens in SS. The combined presence of antibodies to several hnRNPs was strongly associated with connective tissue disease in general and with SS in particular.",

author = "{Op De Beeck}, K and L Maes and Karien Bergh and R Derua and E Waelkens and {Van Steen}, K and P Vermeersch and R Westhovens and {de Vlam}, K and P Verschueren and Hooijkaas, {H (Herbert)} and D Blockmans and X Bossuyt",

year = "2012",

doi = "10.1002/art.33327",

language = "Undefined/Unknown",

volume = "64",

pages = "213--221",

journal = "Arthritis & Rheumatism",

issn = "0004-3591",

publisher = "John Wiley & Sons Ltd.",

number = "1",

}

TY - JOUR

T1 - Heterogeneous nuclear RNPs as targets of autoantibodies in systemic rheumatic diseases

AU - Op De Beeck, K

AU - Maes, L

AU - Bergh, Karien

AU - Derua, R

AU - Waelkens, E

AU - Van Steen, K

AU - Vermeersch, P

AU - Westhovens, R

AU - de Vlam, K

AU - Verschueren, P

AU - Hooijkaas, H (Herbert)

AU - Blockmans, D

AU - Bossuyt, X

PY - 2012

Y1 - 2012

N2 - Objective To investigate the abundance of autoantibodies to heterogeneous nuclear RNPs (hnRNPs) in systemic rheumatic diseases. Methods. Recombinant human hnRNPs A1, B1, C1, E1, F, Gi, H1, I, K, and P2 were prepared. Antibodies to these antigens were determined by Western blotting and by enzyme-linked immunosorbent assay (ELISA) (for hnRNPs B1, E1, F, and H1) in serum samples obtained from patients with chronic fatigue syndrome (control subjects) and from patients with various connective tissue diseases. Results. Western blotting analysis in 106 control subjects and 298 patients with a connective tissue disease revealed that antibodies to all tested hnRNP antigens, except hnRNP Gi, were significantly more prevalent in patients with Sjogren's syndrome (SS) than in control subjects. The highest reactivity was observed for hnRNPs B1, E1, F, and H1 (reactivity in >45% of patients with SS and in 2.8% of control subjects). Reactivity with hnRNPs B1, E1, F, and H1 was also evaluated by ELISA in 89 cont Conclusion. Several hnRNPs are target antigens in SS. The combined presence of antibodies to several hnRNPs was strongly associated with connective tissue disease in general and with SS in particular.

AB - Objective To investigate the abundance of autoantibodies to heterogeneous nuclear RNPs (hnRNPs) in systemic rheumatic diseases. Methods. Recombinant human hnRNPs A1, B1, C1, E1, F, Gi, H1, I, K, and P2 were prepared. Antibodies to these antigens were determined by Western blotting and by enzyme-linked immunosorbent assay (ELISA) (for hnRNPs B1, E1, F, and H1) in serum samples obtained from patients with chronic fatigue syndrome (control subjects) and from patients with various connective tissue diseases. Results. Western blotting analysis in 106 control subjects and 298 patients with a connective tissue disease revealed that antibodies to all tested hnRNP antigens, except hnRNP Gi, were significantly more prevalent in patients with Sjogren's syndrome (SS) than in control subjects. The highest reactivity was observed for hnRNPs B1, E1, F, and H1 (reactivity in >45% of patients with SS and in 2.8% of control subjects). Reactivity with hnRNPs B1, E1, F, and H1 was also evaluated by ELISA in 89 cont Conclusion. Several hnRNPs are target antigens in SS. The combined presence of antibodies to several hnRNPs was strongly associated with connective tissue disease in general and with SS in particular.

U2 - 10.1002/art.33327

DO - 10.1002/art.33327

M3 - Article

C2 - 21905010

SN - 0004-3591

VL - 64

SP - 213

EP - 221

JO - Arthritis & Rheumatism

JF - Arthritis & Rheumatism

IS - 1

ER -